Awarded
PHESGO 1200 mg/600 mg solución para inyección, 1 vial de 15 ml Principio activo: PERTUZUMAB/TRASTUZUMAB
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- ROCHE FARMA, S.A
- Contract value
- €28,931
- Bids received
- 1
- Published
- 25 May 2026
- Awarded
- 4 May 2026
- Contract start
- 4 May 2026
- Contract end
- 24 May 2027estimated
- Region
- Madrid